Conformational Change of the Catalytic Subunit of Glucose-6-phosphatase in Rat Liver during the Fetal-to-Neonatal Transition*

Ferenc PuskásDagger §, Paola MarcolongoDagger , Sharlene L. WatkinsDagger , József Mandl§, Bernard B. Allan, Pamela Houston, Ann Burchell, Angelo BenedettiDagger parallel , and Gábor BánhegyiDagger **

From the Dagger  Istituto di Patologia Generale, Università di Siena, 53100 Siena, Italy, the § Department of Medical Chemistry, Semmelweis University of Medicine, 1444 Budapest, Hungary, and the  Department of Obstetrics and Gynaecology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
REFERENCES

The glucose-6-phosphatase system was investigated in fetal rat liver microsomal vesicles. Several observations indicate that the orientation of the catalytic subunit is different in the fetal liver in comparison with the adult form: (i) the phosphohydrolase activity was not latent using glucose-6-phosphate as substrate, and in the case of other phosphoesters it was less latent; (ii) the intravesicular accumulation of glucose upon glucose-6-phosphate hydrolysis was lower; (iii) the size of the intravesicular glucose-6-phosphate pool was independent of the glucose-6-phosphatase activities; (iv) antibody against the loop containing the proposed catalytic site of the enzyme inhibited the phosphohydrolase activity in fetal but not in adult rat liver microsomes. Glucose-6-phosphate, phosphate, and glucose uptake could be detected by both light scattering and/or rapid filtration method in fetal liver microsomes; however, the intravesicular glucose-6-phosphate and glucose accessible spaces were proportionally smaller than in adult rat liver microsomes. These data demonstrate that the components of the glucose-6-phosphatase system are already present, although to a lower extent, in fetal liver, but they are functionally uncoupled by the extravesicular orientation of the catalytic subunit.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
REFERENCES

Hepatic glucose-6-phosphatase system catalyzing the last step of both gluconeogenesis and glycogenolysis plays a pivotal role in the maintenance and regulation of blood glucose levels (1, 2). Accordingly, a huge increase in the activity of the enzyme can be observed after birth (3, 4). This developmental change forms the liver to be a gluconeogenic organ and serves the adaptation of the organism to the feeding-starvation cycles in the postnatal life. The proper timing of this event is of vital importance; in several cases very low glucose-6-phosphatase activities could be detected in the liver of newborns died in sudden infant death syndrome (5); also, the mean activity of the enzyme was also lower in preterm children (6).

Several factors can contribute to the fetal-to-neonatal transition of the glucose-6-phosphatase system. The postnatal hypoglycemia and the consequently high glucagon/insulin ratio may have a primary role (7). Indeed, it has been reported that dibutyryl cyclic AMP stimulated the transcription of the glucose-6-phosphatase gene in cultured fetal hepatocytes (8). Long chain fatty acids contributed to the induction by the stabilization of the transcript (8). However, the rise in the amount of mRNA and enzyme protein is lower than the dramatic elevation of the activity (9), indicating that other, post-transcriptional factors can also affect the protein(s) of the glucose-6-phosphatase system around the birth.

In adult liver, the catalytic unit of the system is an integral protein of the endoplasmic reticulum membrane. On the basis of its proposed structure (10, 11) and the existence of an intravesicular substrate pool (12), it seems very likely that the loop containing amino acids that contribute to the catalytic site is orientated toward the lumen of the endoplasmic reticulum, in accordance with the compartmentational or substrate transport model (2, 13-16). The phenomenon of latency (the enzyme activity is lower in intact microsomal vesicles than in disrupted ones) and the strict substrate specificity of the phosphohydrolase in intact microsomal vesicles (both determined by the activity/specificity of the substrate transporter T1) can be explained by this topological situation. However, several observations indicate that the compartmentational model is not sufficient in the case of nongluconeogenic organs and tissues, including fetal liver. Diminished latency, altered substrate specificity, different kinetic properties, or unusual lability of the enzyme could be observed in nongluconeogenic organs expressing glucose-6-phosphatase (17), esophagus (18, 19), adult adrenal (20), pancreatic beta -cells (21), skeletal muscle (22), astrocytes (23), etc. Moreover, even the enzyme from the nuclear envelope of adult hepatocytes (24) or the microsomal enzyme prepared from glucocorticoid-treated animals (3, 25) exhibited moderate latency. A recent study indicated that the intravesicular glucose accumulation upon glucose-6-phosphate hydrolysis, a characteristic feature of adult liver microsomes, was absent in microsomes from newborn mice (25). These observations altogether clearly show that the arrangement of the glucose-6-phosphatase system as it can be seen in the endoplasmic reticulum of the adult liver is a special situation supported by developmental and local factors. Therefore, experiments were undertaken to investigate the presence and the characteristics of the phosphohydrolase and the related transport activities in fetal rat liver microsomes and their change around the birth.

    EXPERIMENTAL PROCEDURES

Preparation of Rat Liver Microsomes-- Fetal rat liver microsomes from 18-day-old fetuses and adult rat liver microsomes from male Sprague-Dawley rats (180-230 g) were prepared according to Ref. 26. Microsomal fractions were resuspended in a buffer (buffer A) containing: 100 mM KCl, 20 mM NaCl, 1 mM MgCl2, 20 mM Mops,1 pH 7.2. The suspensions were rapidly frozen and maintained under liquid nitrogen until used. Intactness of microsomal vesicles was checked by investigating the osmotically induced changes in microsomal vesicle size upon the addition of the nonpermeant compound sucrose by the light scattering technique. Microsomes used in this study showed a sustained shrinking upon sucrose addition (see Fig. 1). Microsomal protein concentrations were determined by biuret reaction using bovine serum albumin as standard.

Uptake Measurements-- Liver microsomes (1 mg protein/ml) were incubated in buffer A containing 0.2-30 mM glucose-6-phosphate plus [14C]glucose-6-phosphate (8-10 µCi/ml) or 0.2 mM glucose-1-phosphate plus [14C]glucose-1-phosphate (8-10 µCi/ml) or 1 mM glucose plus [3H]glucose (9 mCi/ml) or 1 mM sucrose plus [14C]sucrose (1 µCi/ml) at 22 °C. In a series of incubations, the pore-forming antibiotic alamethicin (0.05 mg/ml) was added to distinguish the intravesicular and the bound radioactivity (27, 28). The alamethicin-releasable portion of radioactivity was regarded as intravesicular (12). At the indicated time intervals, samples (0.1 ml) were rapidly filtered through cellulose acetate/nitrate filter membranes (pore size, 0.22 µm) and were washed with 4 ml of Hepes (20 mM) buffer, pH 7.2, containing 250 mM sucrose and 0.5 mM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. During the measurement of glucose-6-phosphate or glucose-1-phosphate uptake parallel filters were treated after washing with ZnSO4-Ba(OH)2 to separate glucose from glucose-6-phosphate or glucose-1-phosphate according to Ref. 12. The radioactivity associated with microsomes retained by filters was measured by liquid scintillation counting.

Assay of Glucose-6-phosphatase-- Glucose-6-phosphatase activity was measured after 5 min of incubation in buffer A at 22 °C on the basis of [14C]glucose production from [14C]glucose-6-phosphate according to Ref. 12. Permeabilized microsomes were treated with 0.05 mg alamethicin/mg protein. Alternatively, the phosphohydrolase activity toward various phosphoesters was assayed in native and permeabilized microsomal vesicles on the basis of phosphate measurement according to Ref. 29. Glucose-6-phosphate content of the incubates was measured enzymatically with glucose-6-phosphate dehydrogenase as described in detail earlier (12).

Light Scattering Measurements-- Osmotically induced changes in microsomal vesicle size and shape (30) were monitored at 400 nm at right angles to the incoming light beam using a fluorimeter (Perkin-Elmer model 650-10S) equipped with a temperature-controlled cuvette holder (22 °C) and magnetic stirrer as described elsewhere (31, 32). The mV output signals were acquired at 0.25-s intervals, using a MacLabTM hardware (AD Instruments), equipped with a Chart v3.2.5. software.

Antibodies against Various Sections of the Catalytic Subunit of Glucose-6-phosphatase-- Antibodies specific to 14 amino acid peptides in the glucose-6-phosphatase catalytic subunit were raised in Cheviot sheep. The peptides were synthesized at Severn Biotech Ltd. and received as a lyophilized powder. Sequences of the peptides from the human glucose-6-phosphatase protein against which specific antisera were raised are shown in Table I. Each peptide had an N-terminal cysteine residue added to allow for thiol coupling to the carrier protein, keyhole limpet hemocyanin (Sigma H2133). 20 mg of keyhole limpet hemocyanin was dissolved in 2 ml of 50 mM sodium phosphate (4:1 dibasic to monobasic). The solution was dialyzed overnight against the same buffer at 4 °C. The dialyzed keyhole limpet hemocyanin was treated with 17 µl of 300 mM N-ethylmaleimide (5 µmol). After 30 min 6.2 mg of m-maleimidobenzoyl-N-hydroxy-sulfosuccinimide ester (Pierce 22312) was added, and after a further 30 min the pH was adjusted to 6.0 with 1 N HCl. This mixture was dialyzed overnight at 4 °C against 20 mM NaH2PO4/135 mM NaCl, pH 5.6. An equal volume of 20 mM NaH2PO4/150 mM NaCl, pH 8.0, was added to the dialysate. The pH was adjusted quickly to 6.7. 9 mg of peptide was then added and dissolved by vigorous vortexing. The pH was determined and brought back to 6.7 with 1 N NaOH if necessary. The reaction was over in 2 h, after which the coupled peptide was stored at -20 °C. 185 µg of coupled peptide was injected subcutaneously into Cheviot sheep with Freund's adjuvant on two separate occasions. A third injection of 370 µg was given for peptide A, and two further injections of 370 µg each were given for peptides B, C, and D. Serum from the sheep was stored at -70 °C until use. The four anti-peptide antisera recognize the rat glucose-6-phosphatase catalytic subunit as shown by Western blot analysis.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Sequences of the peptides from the human glucose-6-phosphatase protein

For the determination of the effect of the antibodies on glucose-6-phosphatase activity, native fetal or adult rat microsomes were preincubated in buffer A in the presence of each of the four anti-peptide antibodies for 50 min at room temperature, under continuous agitation. The microsomal protein concentration was 0.35 mg/ml, the antibodies were 100 times diluted in the preincubation mixture. The incubation was started with the addition 10 mM glucose-6-phosphate. The phosphohydrolase activity was detected by measuring glucose or phosphate production (see above).

Western Blot Analysis-- Proteins of the microsomal membranes were separated by electrophoresis on SDS-polyacrylamide gels (15%) and electrophoretically transferred to nitrocellulose (22). Western blots were immunoreacted with a sheep IgG previously shown to be monospecific for the glucose-6-phosphatase catalytic subunit (33). The immonoreactive band was revealed by a biotin-streptavidin horseradish peroxidase-linked detection system with 4-chloro-1-naphthol as the substrate.

Materials-- Glucose-6-phosphate (dipotassium salt), mannose-6-phosphate (dipotassium salt), alamethicin, glucose kit (Trinder method), D-[1-3H(N)]glucose (0.9 mCi/ml; 15.5 Ci/mmol), and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid were obtained from Sigma. D-[14C(U)]glucose-6-phosphate (0.1 mCi/ml; 300 mCi/mmol) was from American Radiolabeled Chemicals Inc. (St. Louis, MO). [U-14C]sucrose 0.2 mCi/ml; 612 mCi/mmol) and D-[14C(U)]glucose-1-phosphate (0.1 mCi/ml; 285 mCi/mmol) were obtained from Amersham Pharmacia Biotech. Cellulose acetate/nitrate filter membranes (pore size, 0.22 µm) were from Millipore. All other chemicals were of analytical grade.

    RESULTS

Transport of Glucose-6-phosphate, Glucose, and Phosphate in Fetal Rat Liver Microsomal Vesicles-- The intactness of the microsomal vesicles and their permeability toward the substrates and products of the glucose-6-phosphatase system were investigated by the light scattering technique. Both fetal and adult microsomal vesicles were practically impermeable toward sucrose, excluding the possibility of the nonspecifically increased permeability. Glucose-6-phosphate was able to enter both types of microsomal vesicles, but the rate of entry was somewhat lower in the fetal microsomes. No major differences could be observed in the permeation of glucose and phosphate (Fig. 1). Other hexose phosphates, which are the substrates of the catalytic subunit, did not permeate the microsomal membrane, their addition caused a prolonged shrinking both in adult and fetal microsomes with the exception of glucose-1-phosphate, which was slowly permeable only in fetal vesicles (Table II).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Influx of glucose-6-phosphate, glucose, and phosphate into liver microsomal vesicles evaluated by a light scattering technique. Light scattering measurements were performed as described under "Experimental Procedures." Light scattering increase was assumed to reflect shrinkage of microsomal vesicles (30, 31). Osmotically induced changes in microsomal vesicle size and shape were initiated by adding 0.1 ml (black arrowhead) of concentrate solutions of sucrose (Sucr), glucose-6-phosphate (G6P), potassium phosphate (Pi, pH 7.0), or glucose (Glc) to 1.5 ml of the microsomal suspensions (in a hypoosmotic buffer at pH 7.0; 70 or 35 µg protein/ml, for adult and fetal microsomes, respectively), giving the final concentration 75 mM (sucrose), 50 mM (glucose), or 30 mM (glucose-6-phosphate and phosphate). Alamethicin (10 µg/ml; open arrowheads) was then added to fully permeabilize microsomal vesicles (28). The addition of the poorly permeable sucrose resulted in a sustained shrinkage of vesicles indicating intactness of microsomal membrane. The recovery of initial signal (swelling phase) after glucose-6-phosphate, glucose, or potassium phosphate addition was assumed to reflect their entry into vesicles. The shrinking phase (dotted lines) has been graphically reconstructed by taking into account the loss of the light scattering intensity due to dilution of microsomal suspensions after solute additions. Traces are representative of two to five separate measurements.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Latency of the phosphohydrolase activity towards various sugar phosphoesters in fetal and adult rat liver microsomes
Microsomal vesicles (1 mg protein/ml) were incubated in buffer A in the presence of various phosphoesters (10 mM) for 30 min (fetal) or 5 min (adult) at room temperature. Phosphate production was measured. Permeabilized microsomes were treated with 50 µg/ml alamethicin. Data are the means ± S.D. of three to six experiments. The influx rates of the phosphoesters (25 mM) into microsomal vesicles expressed as half-time of the light scattering signal are also shown (n = 2-5).

Transport activities were also assessed using radiolabeled compounds and a rapid filtration method. Fetal rat liver microsomes incubated in the presence of various concentrations of glucose-6-phosphate (plus [14C]glucose-6-phosphate as a tracer) rapidly accumulated glucose-6-phosphate + glucose reaching a steady-state level in 2 min. More than 90% of the radioactivity associated to the microsomes was releasable by the pore-forming alamethicin, indicating the intravesicular accumulation. In contrast to adult microsomes, fetal vesicles did not accumulate the isotope over the equilibrium. Separate measurement of glucose-6-phosphate and glucose revealed that both compounds were present in the intraluminal space of vesicles; however, the amount of the intravesicular glucose was very low compared with that of adult microsomes and hardly reached the detection limit (Table III). Upon glucose-1-phosphate addition (which is a poor substrate of the phosphohydrolase, see Table II), the difference in the intravesicular isotope accumulation was much less expressive between fetal and adult microsomes, due to the very low glucose production (Table III).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Uptake and hydrolysis of glucose-6-phosphate in fetal rat liver microsomal vesicles
Liver microsomes (1 mg/ml) were incubated in buffer A containing 0.2 glucose-6-phosphate (in some experiments glucose-1-phosphate) plus [14C]glucose-6-phosphate ([14C]glucose-1-phosphate) (8-10 µCi/ml). In a series of incubations the pore-forming antibiotic alamethicin (0.05 mg/ml) was added to distinguish the intravesicular and the bound radioactivity. The alamethicin releasable (i.e. intravesicular) portion of radioactivity is shown. At the steady-state level of uptake (5-10 min), samples (0.1 ml) were rapidly filtered and washed; the intravesicularly accumulated glucose deriving from glucose-6-phosphate (glucose-1-phosphate) hydrolysis during the measurement of glucose-6-phosphate uptake was measured parallelly as described under "Experimental Procedures." For the measurement of intravesicular glucose and sucrose spaces, 1 mM glucose plus [3H]glucose (9 mCi/ml) or 1 mM sucrose plus [14C]sucrose (1 µCi/ml) were incubated with microsomal vesicles for 2 h at 22 °C. At the end of the incubation the intravesicular radioactivity was assessed as described for glucose-6-phosphate. Apparent intravesicular isotope spaces were calculated according to the formula: apparent intravesicular space (µl/mg protein) = intravesicular accumulation (nmol/mg protein)/concentration of the added compound (nmol/µl). The same measurements were also executed on adult rat liver microsomal vesicles. The abbreviations used in the table are: G6P, glucose-6-phosphate; G1P, glucose-1-phosphate; NM, not measurable.

The steady-state level of intravesicular glucose-6-phosphate increased linearly by increasing the extravesicular concentration of glucose-6-phosphate. Consequently, the intravesicular glucose-6-phosphate accessible space (calculated by dividing the amount of accumulated glucose-6-phosphate by the extravesicular glucose-6-phosphate concentration) was independent of the glucose-6-phosphate concentration in the medium (Fig. 2).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   The intravesicular glucose-6-phosphate space in fetal rat liver microsomal vesicles. Microsomes were incubated in the presence of 0.2-30 mM glucose-6-phosphate plus [14C]glucose-6-phosphate as tracer for 5 min. The glucose-6-phosphatase activities and the intravesicular glucose-6-phosphate contents were measured (for details see the legend to Table III). The glucose-6-phosphate-accessible intravesicular space of microsomes was calculated using the following formula: intravesicular glucose-6-phosphate space (µl/mg protein) = intravesicular glucose-6-phosphate content (nmol/mg protein)/extravesicular glucose-6-phosphate concentration (nmol/µl). Glucose-6-phosphate space is shown as a function of both extravesicular glucose-6-phosphate concentration (open symbols) and microsomal glucose-6-phosphatase activity (filled symbols). The values are the means ± S.D. of three to six experiments.

Fetal rat liver microsomal vesicles incubated in the presence of 1 mM glucose took up the radioactive tracer until a steady-state level reached over a 5-min period of incubation (Fig. 3). The uptake was attributable to intravesicular accumulation, because the majority of radioactivity (>90%) could be released by permeabilizing the vesicles with the pore-forming alamethicin. The steady-state level of intravesicular glucose was stable for at least 2 h. In the steady-state phase of glucose uptake, the apparent intravesicular glucose space, which was calculated by dividing the intravesicular glucose content (nmol/mg protein) with the extravesicular glucose concentration (nmol/µl), was 0.23 ± 0.04 (µl/mg protein) at 1 mM glucose concentration. This apparent space was about 50% of that observed in adult rat liver microsomes by using the same method (Table III).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Glucose uptake by fetal rat liver microsomal vesicles. Microsomes were incubated in the presence of 1 mM glucose plus [3H]glucose as tracer and intravesicular glucose contents were measured as detailed under "Experimental Procedures." The data are the means ± S.D. of four experiments.

Because the intravesicular glucose-6-phosphate, glucose-1-phosphate, and glucose accessible spaces of fetal liver microsomes were lower than the corresponding maximal values obtained in adult microsomes, we have estimated the total intravesicular space measuring the sucrose accessible space of microsomes. Sucrose, a poorly permeant compound, reached a steady-state level of uptake at 2 h of incubation. The value of the intravesicular sucrose space was also 2-fold higher in adult rat liver microsomes (Table III).

Glucose-6-phosphatase Activity in Fetal Rat Liver Microsomal Vesicles-- The total phosphohydrolase activity in fetal microsomes was less than 5% of the adult value (Tables II and IV). According to Western blot analysis, the amount of the enzyme protein was less than in adult microsomes, yet it was clearly detectable (Fig. 4). The latency of the enzyme was almost absent; permeabilization of the vesicles elevated the activity slightly, whereas in adult microsomes more than 50% of the activity was latent (Table II). The difference in glucose-6-phosphatase activities obtained by the addition of various concentrations of glucose-6-phosphate did not affect the extent of the intravesicular glucose-6-phosphate accessible space (Fig. 2.).

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Effect of antibodies against various sections of glucose-6-phosphatase on its catalytic activity in fetal and adult rat liver microsomes
Native microsomes (0.35 mg protein/ml) were preincubated buffer A in the presence of each of the four anti-peptide antibodies (1% of the incubation volume) for 50 min at room temperature under continuous agitation. The incubations were started with the addition 10 mM glucose-6-phosphate. The phosphohydrolase activity was detected by measuring glucose or phosphate production. Data are the means ± S.D. of 4-9 measurements.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4.   Immunoblot analysis of fetal and adult rat liver microsomes. 5 and 10 µg (adult; lanes 1 and 2) or 10 µg (fetal; lane 3) of microsomal protein was loaded. The arrow indicates a 38-kDa molecular mass.

Hydrolysis of other phosphoesters (10 mM) by fetal microsomes showed diminished latency compared with adult microsomes (Table II). Very moderate latency was observed in the case of glucose-1-phosphate and fructose-6-phosphate, whereas the phosphohydrolase activity toward mannose-6-phosphate, deoxyglucose-6-phosphate, and glucosamine-6-phosphate remained latent in two-thirds. The eventual conversion of the hexose phosphates to glucose-6-phosphate during the incubation (which has been reported in brain microsomes, for example; Ref. 23) was checked by measuring the glucose-6-phosphate content at 0 and 30 min of incubation. We have found low glucose-6-phosphate contents, presumably due to the impurity of chemicals. The highest value, in the case of fructose-6-phosphate, was 0.04 mM at the start of incubation (0.4% of the added fructose-6-phosphate) and 0.07 mM at 30 min. Other incubates contained less than 0.01 mM glucose-6-phosphate, a value that did not increase during the incubation (data not shown).

Inhibition of the Phosphohydrolase Activity by Antibodies Against Different Sections of Glucose-6-phosphatase-- Native fetal and adult microsomal vesicles were preincubated in the presence of antibodies raised against different sections of glucose-6-phosphatase: the N- and C-terminal parts, an external loop, and an internal loop containing the His residue that belongs to the active site of the enzyme. After 50 min of preincubation 10 mM glucose-6-phosphate was added, and the glucose-6-phosphatase activities were measured. In adult microsomes neither of the antibodies affected the phosphohydrolase activity. On the contrary, in fetal microsomes antibodies A and D, raised against two loops supposed to be orientated toward the cytosol and the lumen in adult liver, strongly inhibited the enzyme (Table IV).

    DISCUSSION

The results of the present study demonstrate that the components of the hepatic glucose-6-phosphatase system are already present in the fetal liver, although at a lower extent. In accordance with earlier studies the catalytic subunit of the enzyme can be demonstrated by Western blotting, although the microsomal phosphohydrolase activity in fetal liver is less than the 5% of the adult one. The transporters belonging to the system (T1, T2, and T3) are also present, because microsomal transport of glucose-6-phosphate, glucose, and phosphate can also be detected by uptake measurements. However, the intraluminal glucose-6-phosphate and glucose spaces are 40-50% of the values observed in adult rat liver microsomal vesicles. These alterations might suggest that the corresponding transporters are present in a lower percentage of fetal microsomal vesicles. More probably, they can reflect the differences in the protein content and/or vesicle size between fetal and adult microsomal preparations. This latter possibility is supported by the facts that (i) the light scattering behavior of fetal and adult microsomes is similar in the presence of glucose or glucose-6-phosphate and (ii) the intravesicular sucrose space, which is nearly as extensive as the intravesicular water space (32), is proportionally lower in fetal microsomes.

Beyond the quantitative differences, fetal liver microsomes also differ qualitatively. Permeabilization of the microsomal vesicles by alamethicin slightly increases the phosphohydrolase activity, i.e. the latency of the enzyme is minimal. Using other substrates than glucose-6-phosphate, we have also observed reduced latency that is accompanied with a reduced substrate specificity. The intravesicular accumulation of glucose due to glucose-6-phosphate hydrolysis is hardly measurable, in accordance with the observation of Annabi and van de Werve (25). The intravesicular glucose-6-phosphate space, which is in inverse ratio to the extravesicular glucose-6-phosphate concentration and the consequent glucose-6-phosphatase activity in adult rat liver microsomes (12), is stable independently of extravesicular glucose-6-phosphate concentrations. It suggests that in fetal rat liver microsomes glucose-6-phosphatase does not utilize an intravesicular substrate pool.

The differences between fetal and adult glucose-6-phosphatase system can be explained in several ways. The nonspecific increase of membrane permeability in fetal microsomal vesicles is out of the question on the basis of normal sucrose response in light scattering and the presence of intravesicular pools. The altered (diminished) specificity of glucose-6-phosphate transporter and/or the presence of other transporter(s) responsible for the permeation of other phosphoesters may also be supposed. However, other hexose-6-phosphates are not permeable on the basis of light scattering experiments. Furthermore, the altered balance of transport and hydrolysis, i.e. the very low phosphohydrolase activity together with the quasi normal transport processes, may cease the rate-limiting property of glucose-6-phosphate transport, which is characteristic of adult microsomes. This explanation can account for the diminished latency of the system in the presence of glucose-6-phosphate and the low intravesicular glucose accumulation upon glucose-6-phosphate hydrolysis. In itself it is not enough to explain the decreased latency of phosphohydrolase toward other phosphoesters. On the basis of the results we suppose that the changed orientation of the proposed active site of glucose-6-phosphatase can be responsible for the altered features of glucose-6-phosphatase system in fetal rat liver microsomes. This feature of the enzyme is not without precedents: multiple topological orientations linked with different functions has been reported in the case of other membrane proteins (34-36). The premise of the presence of a phosphohydrolase orientated with its catalytic site toward the cytosolic surface of the endoplasmic reticulum membrane is compatible with the reduced latency, the relative substrate specificity in native microsomes, the phosphohydrolase-independent intravesicular glucose-6-phosphate pool, and the small intravesicular glucose accumulation. The inhibitory effect of an antibody against the loop containing the proposed active site of the enzyme, which was present only in the fetal microsomal vesicles, strongly supports this hypothesis. Because glucose-6-phosphate transport is present in fetal microsomes, it means that the transport and hydrolysis are at least partially uncoupled. Due to the altered orientation, the enzyme can act as a rather nonspecific phosphohydrolase or, alternatively, can catalyze the inverse reaction (37), i.e. it may replace the glucokinase activity missing in the neonatal period (38).

It has been observed previously that the latency of the glucose-6-phosphatase system (and other microsomal enzymes with different time course; Ref. 39) increases rapidly around the birth. It may be caused by the change of orientation of the enzyme or by the replacement of the fetal isozyme with an adult form. In the first case it can be supposed that the folding of the protein converts it into a more active, more specific, intralumenally orientated form. The activation of preformed proteins by folding together with the increased transcription of glucose-6-phosphatase gene may serve the rapid accommodation to the new gluconeogenic/glycogenolytic role of the liver after the birth.

    FOOTNOTES

* This work was supported by Italian Telethon Grant E.638 (to A. Benedetti), by Hungarian-Italian Intergovernmental S & T Cooperation Programme Grant I-44/95, and by funds from the Medical Research Council and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

parallel To whom correspondence should be addressed: Istituto di Patologia Generale, Università di Siena, Viale Aldo Moro, 53100 Siena, Italy. Tel.: 39-0577-227021; Fax: 39-0577-227009; E-mail: benedetti{at}unisi.it.

** Recipient of an Eötvös Hungarian State Fellowship and a NATO-CNR Senior Guest Fellowship to Siena.

    ABBREVIATIONS

The abbreviation used is: Mops, 4-morpholinepropanesulfonic acid..

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
REFERENCES
  1. Nordlie, R. C., and Sukalski, K. A. (1985) in The Enzymes of Biological Membranes (Martonosi, A. N., ed), pp. 349-398, Plenum Press, New York
  2. Chen, Y. T., and Burchell, A. (1995) in The Metabolic Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds), pp. 935-965, McGraw-Hill, New York
  3. Burchell, A., and Leakey, J. E. A. (1988) Biol. Neonate 54, 107-115[Medline] [Order article via Infotrieve]
  4. Burchell, A., Gibb, L., Waddell, I. D., Giles, M., and Hume, R. (1990) Clin. Chem. 36, 1633-1637[Abstract/Free Full Text]
  5. Burchell, A., Bell, J. E., Busuttil, A., and Hume, R. (1989) Lancet 2, 291-294[Medline] [Order article via Infotrieve]
  6. Hume, R., and Burchell, A. (1993) Arch. Dis. Child. 68, 202-204[Abstract]
  7. Girard, J., and Pégorier, J.-P. (1998) Biochem. Soc. Trans. 26, 69-74[Medline] [Order article via Infotrieve]
  8. Chatelain, F., Pégorier, J.-P., Minassian, C., Bruni, N., Tarpin, S., Girard, J., and Mithieux, G. (1998) Diabetes 47, 882-889[Abstract]
  9. Watkins, S. L., Scott, H. M., and Burchell, A. (1995) Biochem. Soc. Trans. 23 (suppl.), 436
  10. Hemrika, W., and Wever, R. (1997) FEBS Lett. 409, 317-319[CrossRef][Medline] [Order article via Infotrieve]
  11. Pan, C.-J., Lei, K.-J., Annabi, B., Hemrika, W., and Chou, J. Y. (1998) J. Biol. Chem. 273, 6144-6148[Abstract/Free Full Text]
  12. Bánhegyi, G., Marcolongo, P., Fulceri, R., Hinds, C., Burchell, A., and Benedetti, A. (1997) J. Biol. Chem. 272, 13584-13590[Abstract/Free Full Text]
  13. Arion, W. J., Wallin, B. K., Lange, A. J., and Ballas, L. M. (1975) Mol. Cell. Biochem. 6, 75-83[Medline] [Order article via Infotrieve]
  14. Arion, W. J., Lange, A. J., Walls, H. E., and Ballas, L. M. (1980) J. Biol. Chem. 255, 10396-10406[Abstract/Free Full Text]
  15. Burchell, A. (1990) FASEB J. 4, 2978-2988[Abstract]
  16. Waddell, I. D., and Burchell, A. (1991) Biochem. J. 275, 133-137[Medline] [Order article via Infotrieve]
  17. Burchell, A., Watkins, S. L., and Hume, R. (1996) Biol. Reprod. 55, 298-303[Abstract]
  18. Hume, R., and Burchell, A. (1996) Histochem. J. 28, 141-147[Medline] [Order article via Infotrieve]
  19. McIntosh, K., Hume, R., and Burchell, A. (1996) Biochem. Soc. Trans. 24, 243S[Medline] [Order article via Infotrieve]
  20. Hume, R., Voice, M., Pazouki, S., Giunti, R., Benedetti, A., and Burchell, A. (1995) J. Clin. Endocrinol. Metab. 80, 1960-1966[Abstract]
  21. Waddell, I. D., and Burchell, A. (1988) Biochem. J. 255, 471-476[Medline] [Order article via Infotrieve]
  22. Gamberucci, A., Marcolongo, P., Fulceri, R., Giunti, R., Watkins, S. L., Waddell, I. D., Burchell, A., and Benedetti, A. (1996) Mol. Membr. Biol. 13, 103-108[Medline] [Order article via Infotrieve]
  23. Forsyth, R. J., Bartlett, K., Burchell, A., Scott, H. M., and Eyre, J. A. (1993) Biochem. J. 294, 145-151[Medline] [Order article via Infotrieve]
  24. Gonzalez-Mujica, F., Waddell, I. D., and Burchell, A. (1993) Biochem. Soc. Trans. 22, 39S
  25. Annabi, B., and van de Werve, G. (1997) Biochem. Biophys. Res. Commun. 236, 808-813[CrossRef][Medline] [Order article via Infotrieve]
  26. Henne, V., and Söling, H. D. (1986) FEBS Lett. 202, 267-273[CrossRef][Medline] [Order article via Infotrieve]
  27. Ojcius, D. M., and Young, J. D.-E. (1991) Trends Biochem. Sci. 16, 225-229[Medline] [Order article via Infotrieve]
  28. Fulceri, R., Bánhegyi, G., Gamberucci, A., Giunti, R., Mandl, J., and Benedetti, A. (1994) Arch. Biochem. Biophys. 309, 43-46[CrossRef][Medline] [Order article via Infotrieve]
  29. Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., and Candia, O. A. (1979) Anal. Biochem. 100, 95-97[Medline] [Order article via Infotrieve]
  30. Meissner, G. (1988) Methods Enzymol. 157, 417-437[Medline] [Order article via Infotrieve]
  31. Fulceri, R., Gamberucci, A., Scott, H. M., Giunti, R., Burchell, A., and Benedetti, A. (1995) Biochem J. 307, 391-397[Medline] [Order article via Infotrieve]
  32. Marcolongo, P., Fulceri, R., Giunti, R., Burchell, A., and Benedetti, A. (1996) Biochem. Biophys. Res. Commun. 219, 916-922[CrossRef][Medline] [Order article via Infotrieve]
  33. Burchell, A., Waddell, I. D., Countaway, J. L., Arion, W. J., and Hume, R. (1988) FEBS Lett. 242, 153-156[CrossRef][Medline] [Order article via Infotrieve]
  34. Levy, D. (1996) Essays Biochem. 31, 49-60[Medline] [Order article via Infotrieve]
  35. Zhang, J.-T., and Ling, V. (1991) J. Biol. Chem. 266, 18224-18232[Abstract/Free Full Text]
  36. Zhang, J.-T., Duthie, M., and Ling, V. (1993) J. Biol. Chem. 268, 15101-15110[Abstract/Free Full Text]
  37. Foster, J. D., Pederson, B. A., and Nordlie, R. C. (1997) Proc. Soc. Exp. Biol. Med. 203, 274-285[Medline] [Order article via Infotrieve]
  38. Postic, C., Leturque, A., Printz, R. L., Maulard, P., Loizeau, M., Granner, D. K., and Girard, J. (1994) Am. J. Physiol. 266, E548-E559[Abstract/Free Full Text]
  39. Takahashi, T., and Hori, S. H. (1981) Biochim. Biophys. Acta 672, 165-175[Medline] [Order article via Infotrieve]
  40. Bánhegyi, G., Marcolongo, P., Burchell, A., and Benedetti, A. (1998) Arch. Biochem. Biophys., in press


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.